IIL partners with the University of Griffith, Australia to develop coronavirus vaccine:
Indian Immunologicals (IIL), a vaccine maker, collaborated with Australia`s Griffith University to do research and create a COVID-19 vaccine. In this respect the two organizations have signed a agreement.
Highlights:
♦ Under the partnership Scientists from India and Australia will develop a `live attenuated SARS–CoV-2 vaccine` using the latest codon deoptimization technology.
♦ IIL stated that the technology looks promising for developing a vaccine for prophylactic, active, single-dose immunization against novel coronavirus in humans, with an enhanced safety profile.
♦ The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunization.
♦ Upon the completion of the research, the vaccine strain will be transferred to ILL. It will work with the Central Drugs Standard Control Organisation (CDSCO), to conduct clinical trials. IIL intends to use its Vero cell platform tech for mass production of the vaccine.
♦ IIL is promoted by the National Dairy Development Board. It is committed to addressing critical public health needs by engaging in this collaboration.
######